March 9, 2021 March 9, 2021ANI Pharmaceuticals to Acquire Novitium Pharma, Strengthening R&D Engine and Expanding Generics and CDMO Business
March 8, 2021 March 8, 2021Arranta Bio Announces Addition of 130,000 sq. ft. Boxborough, Mass., Manufacturing Facility to Supply Clinical and Commercial Microbiome Products for Clients and closes Series B Equity Financing
January 20, 2021 January 20, 2021Nexelis acquires the GSK vaccines clinical bioanalytical laboratory located in Marburg – Germany and enters into a 5-year strategic agreement with GSK
January 15, 2021 January 15, 2021Announcing vivitide, a New Name With Continuous Commitment to Science Based on Long Experience in the World of Peptides and Antibodies
January 5, 2021 January 5, 2021Genezen Laboratories Receives Growth Equity Investment from Ampersand Capital Partners
November 19, 2020 November 19, 2020Ampersand Announced Today the $670 Million Closing of the Ampersand Continuation Fund (“AMP-CF”) with Confluent Medical Technologies as Core Asset